Status:

COMPLETED

P300 in Early Cognitive Impairment in Hepatitis C Virus

Lead Sponsor:

Mansoura University Hospital

Conditions:

Hepatitis C

Cognitive Impairment

Eligibility:

All Genders

Brief Summary

Approximately 50% of patients with hepatitis C have complaints of fatigue and cognitive deficits even before the development of significant hepatic impairment.

Detailed Description

Assessing the influence of HCV infection on the development of cognitive changes involves many challenges. The frequent presence of confounding factors such as illicit drug use, depression, and cirrho...

Eligibility Criteria

Inclusion

  • Newly diagnosed HCV infection

Exclusion

  • Any neuropsychiatric disease that cause impaired cognition

Key Trial Info

Start Date :

February 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04389268

Start Date

February 1 2018

End Date

February 1 2019

Last Update

May 15 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mansoura University Hospital

Al Mansurah, Egypt